This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovator Spotlight: Thomas Stephen Collings
Introduction: Thomas Stephen Collings, based in Cambridgeshire, GB, is a notable inventor recognized for his contribution to the medical field through his innovative inventions. With a focus on enhancing patient care, he has developed solutions that improve the administration of medicaments.
Latest Patents: Thomas is credited with one significant patent: a dry powder inhaler. This invention relates to a device designed for administering medication via the oral inhalation route. The innovation is particularly valuable as it enables the delivery of accurate doses of medicament tailored to different ranges of inspiratory capacity of the subject, thus enhancing the efficiency of the treatment process.
Career Highlights: Thomas is currently employed at Glenmark Pharmaceuticals Limited, a company dedicated to providing high-quality pharmaceuticals. His work there reflects his commitment to advancing medical technology and improving therapeutic outcomes for patients.
Collaborations: Throughout his career, Thomas has collaborated with fellow professionals, including Ulhas R Dhuppad and Rachel Striebig. These collaborations highlight the importance of teamwork in driving innovation and improving healthcare solutions.
Conclusion: Thomas Stephen Collings exemplifies the spirit of innovation in the medical field. His patent for the dry powder inhaler showcases his dedication to improving patient care. As he continues to work with Glenmark Pharmaceuticals Limited and his colleagues, the future holds great promise for further advancements in respiratory therapies.